XRCC5 and cancer: K568 is in the CTR region of Ku80 at the DNA binding border.31,32 Previous studies have reported that knockout of Ku80 in human cells resulted in lethality.42,43 In this study, although we generated Ku80 knockdown cancer cells, this could be a hybrid clone instead of monoclonal.